NPI | Name | Type | Address |
---|---|---|---|
Barbara Cmuchowski |
Individual |
35 Park St New Haven, CT |
|
MR. R.PH., BCOP Thomas Michael Ferencz |
Individual |
55 Park St New Haven, CT |
|
PHARMD Alexandra Igoumenos |
Individual |
55 Park St New Haven, CT |
|
DR. PHARMD Marc Daniel Iannaccone |
Individual |
1100 Sherman Ave Hamden, CT |
|
Andrew Kowalski |
Individual |
55 Park St New Haven, CT |
|
DR. PHARMD, BCOP Mary Lauren Elizabeth Willis |
Individual |
4251 Mooncoin Way Lexington, KY |
|
Sergio F Toni JR. |
Individual |
20 York St New Haven, CT |
|
PHARMD Ryan Miller |
Individual |
1301 Medical Center Dr Ste 3907 Nashville, TN |
|
DR. PHARMD. Matthew Perciavalle |
Individual |
1301 Medical Center Dr Oncology Pharmacy Nashville, TN |
|
PHARMD Bradley Yelvington |
Individual |
1301 Medical Center Dr Rm 3907 Nashville, TN |
|
PHARMD, BCOP, BCPS Crystal Leung |
Individual |
9090 Wilshire Blvd Ste 250 Beverly Hills, CA |
|
PHARMD Terry Kheng Pak |
Individual |
1275 York Ave Ste 712 New York, NY |
|
PHARM.D. Tiffany Lin |
Individual |
8700 Beverly Blvd West Hollywood, CA |
|
DR. PHARMD Mark Wysocki |
Individual |
55 Park St New Haven, CT |
|
PHARMD Kyung Kim |
Individual |
9090 Wilshire Blvd Ste 250 Beverly Hills, CA |
|
MRS. BS PHARM., BCOP Nancy Jane Beaulieu |
Individual |
19 Lunar Dr Woodbridge, CT |
|
BSPHARMACY Robert James Marussich |
Individual |
77 Lafayette Pl Ste 200 Greenwich, CT |
|
PHARMD Bradley Figgins |
Individual |
1275 York Ave New York, NY |
|
Jonathan Aston |
Individual |
1301 Medical Center Dr Rm 2906 Nashville, TN |
|
Brenda Yik |
Individual |
55 Park St New Haven, CT |
Every health care provider, whether it’s a hospital, pharmacy, or individual specialist, must obtain their own NPI number. This identification number is unique and is assigned upon application. In tod...
Taxonomy Code | 1835X0200X |
Specialization | Oncology |
Display Name | Oncology Pharmacist |
Taxonomy Group | Pharmacy Service Providers |
Taxonomy Classification | Pharmacist |
Definition | A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases. |
Effective Date | September 30, 2009 |